Beyond glucose control: SGLT2 inhibitors' impact on hematological parameters in lupus nephritis patients

被引：0
|
作者：
Mohamed, Nourelsabah [1 ]
Refaie, Ayman F. [1 ]
Zayed, Karem N. [2 ]
Mortada, Wael I. [3 ]
Nabieh, Kareem A. [3 ]
Sobh, Mohamed A. [1 ]
机构：
[1] Mansoura Univ, Dialysis & Transplantat Unit, Urol & Nephrol Ctr, Mansoura, Egypt
[2] Mansoura Univ, Mansoura Nephrol & Dialysis Unit MNDU, Fac Med, Mansoura, Egypt
[3] Mansoura Univ, Urol & Nephrol Ctr, Clin Chem Lab, Mansoura, Egypt
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2275
引用
收藏
页码：I657 / I657
页数：1
相关论文
共 50 条
  • [21] Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1
    Sayour, Alex Ali
    Ruppert, Mihaly
    Olah, Attila
    Benke, Kalman
    Barta, Balint Andras
    Zsary, Eszter
    Merkely, Bela
    Radovits, Tamas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [22] Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
    Unno, Keiko
    Taguchi, Kyoko
    Takagi, Yoshiichi
    Hase, Tadashi
    Meguro, Shinichi
    Nakamura, Yoriyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [23] Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion
    Hattersley, Andrew T.
    Thorens, Bernard
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10): : 974 - 976
  • [24] Response to: Correspondence on ?SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Qi, Yuan-yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (06)
  • [25] Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
    Youssef, Mahmoud E.
    Yahya, Galal
    Popoviciu, Mihaela Simona
    Cavalu, Simona
    Abd-Eldayem, Marwa A.
    Saber, Sameh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [26] SGLT2 Inhibitors and Safety in Older Patients
    Pollack, Rena
    Cahn, Avivit
    HEART FAILURE CLINICS, 2022, 18 (04) : 635 - 643
  • [27] SGLT2 inhibitors may offer benefit beyond diabetes
    Amy Kang
    Meg J. Jardine
    Nature Reviews Nephrology, 2021, 17 : 83 - 84
  • [28] SGLT2 Inhibition in Nondiabetic CKD: Results in Experimental Lupus Nephritis (LN)
    Vilardell, Jordi
    Jacobs Cacha, Conxita
    Martos, Nerea
    Llorens Cebria, Carmen
    Motto, Aku Enam
    Lech, Maciej
    Martinez Diaz, Irene
    Anders, Hans J.
    Soler, Maria Jose
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [29] SGLT2 inhibitors: well beyond a smart diuretic effect
    Oliveira, C.
    Agostinho, J. R.
    Couto Pereira, S.
    Silverio Antonio, P.
    Alves Da Silva, P.
    Brito, J.
    Garcia, B.
    Martins, A. M.
    Rigueira, J.
    Silva, D.
    Santos, R.
    Lousada, N.
    Pinto, J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 123 - 123
  • [30] SGLT2 Inhibitors are Associated with Improved Clinical and Hemodynamic Parameters in LVAD Patients
    Fardman, A.
    Kodesh, A.
    Siegel, A.
    Regev, E.
    Berkovitch, A.
    Morgan, A.
    Grupper, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S451 - S451
12345